martes, 2 de octubre de 2018

Decibel Gets Exclusive Rights for ORC-13661 for Ototoxicity, a Risk in CF

Decibel Gets Exclusive Rights for ORC-13661 for Ototoxicity, a Risk in CF

Cystic Fibrosis News Today



Decibel Obtains Exclusive License for ORC-13661 for Prevention of Antibiotic-related Ototoxicity

 OCTOBER 2, 2018
Diogo PintoBY DIOGO PINTO
 
IN CYSTIC FIBROSIS, NEWS.
Decibel Obtains Exclusive License for ORC-13661 for Prevention of Antibiotic-related Ototoxicity
en

No hay comentarios:

Publicar un comentario